Denis A. Poddubnyy
Distinguished in Non-Radiographic Axial Spondyloarthritis (nr-axSpA)

Denis A. Poddubnyy

Infectiology And Rheumatology
Berlin, BE, DE 
Distinguished in Non-Radiographic Axial Spondyloarthritis (nr-axSpA)
Infectiology And Rheumatology
Berlin, BE, DE 
OverviewLocationsClinical Research

Overview

Denis Poddubnyy practices in Berlin, Germany. Mr. Poddubnyy is rated as a Distinguished expert by MediFind in the treatment of Non-Radiographic Axial Spondyloarthritis (nr-axSpA). His top areas of expertise are Axial Spondyloarthritis (AxSpA), Ankylosing Spondylitis, Arthritis, and Psoriatic Arthritis.

His clinical research consists of co-authoring 315 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Non-Radiographic Axial Spondyloarthritis (nr-axSpA).

Gender
Male

Locations

Infectiology and Rheumatology
Berlin, BE, Germany
Other Locations
Potsdam, BB, Germany
Infectiology and Rheumatology, Charité Universitätsmedizin Berlin
Mitte, BE, Germany
Germany
Hagen, NW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients With Axial Spondyloarthritis
A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients With Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: June 13, 2022
Intervention Type: Drug
Study Phase: Phase 3
COmparison of the Effect of Treatment With NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of StrUctural Damage in the Spine Over Two Years in Patients With ankyLosing Spondylitis: a Randomized Controlled Multicentre Trial
COmparison of the Effect of Treatment With NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of StrUctural Damage in the Spine Over Two Years in Patients With ankyLosing Spondylitis: a Randomized Controlled Multicentre Trial
Enrollment Status: Completed
Publish Date: January 27, 2021
Intervention Type: Drug, Biological
Study Phase: Phase 4
View 1 Less Clinical Trial

315 Total Publications

Dr. Gensler et al reply.
Dr. Gensler et al reply.
Journal: The Journal of rheumatology
Published: October 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Poddubnyy's expertise for a condition
ConditionClose
View All 26 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile